Drug
Spn 804o
Spn 804o: highest development phase Phase 1, developed by Supernus Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Supernus Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| SPN-804O NCT00918047 | Phase 1 | Epilepsies, Partial |
Latest
No recent events.
Follow Spn 804o on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.